Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07418177RecruitingPhase 1/Phase 2
Stem cell transplant for late-stage age-related macular degeneration
This trial tests a new treatment for advanced age-related macular degeneration (AMD) where doctors transplant lab-grown retinal cells (from stem cells) under the retina to try to replace damaged cells and improve or preserve vision. It is for people with severe vision loss from either dry AMD (large area of dead tissue) or old wet AMD that has stopped leaking.
Nanjing, JiangsuAges 50–85 - NCT01306019RecruitingPhase 1/Phase 2
Gene therapy for severe combined immunodeficiency in older children and adults
This trial tests a one-time gene therapy that aims to fix the genetic problem causing X-linked severe combined immunodeficiency (XSCID). It is for people aged 2 to 50 who lack a matched sibling donor and have persistent immune problems.
Bethesda, MarylandAges 2–50 - NCT07881666RecruitingPhase 1
Vaccine for bladder cancer after standard treatment fails
This study tests an investigational vaccine for people with a type of bladder cancer that has come back after receiving standard treatments (BCG or chemotherapy into the bladder). The vaccine is designed to help the immune system fight the cancer. It may be an option if your cancer is limited to the lining of the bladder and you are otherwise in good health.
Kfar Saba, Central DistrictAges 18 years+ - NCT05934331RecruitingPhase 2
Combination therapy for advanced gastrointestinal tumors
This trial tests a new drug called LM-302 combined with other cancer treatments for people with advanced stomach, esophageal, or other gastrointestinal cancers that have stopped responding to standard first-line treatment. The goal is to see if the combination is safe and effective.
ShanghaiAges 18–80 - NCT07881588Recruiting
Diabetes foot artery risk prediction study
This study aims to build a tool that predicts the risk of developing blocked arteries in the legs (a condition called arteriosclerosis obliterans) in people with type 2 diabetes. By identifying risks early, patients can take steps to prevent serious complications.
Nanchang, Jang XIAges 18 years+ - NCT07422480RecruitingPhase 3
Comparing two anemia treatments for myelodysplastic syndromes
This trial tests a new medicine (elritercept) against a standard treatment (epoetin alfa) for anemia in people with lower-risk myelodysplastic syndromes who need regular blood transfusions. The goal is to see which one works better to reduce transfusion needs and improve blood counts.
Gilbert, ArizonaAges 18 years+ - NCT06405633RecruitingPhase 1/Phase 2
A study of a new treatment for alpha-1 antitrypsin deficiency
This study tests an experimental drug for people with a specific type of alpha-1 antitrypsin deficiency (Pi*ZZ). It aims to see if the drug is safe and whether it can help improve lung or liver problems caused by the condition.
Fitzroy, VictoriaAges 18–70 - NCT07789106Recruiting
Coenzyme Q10 study for tiredness and strength while on weight-loss injections
This study tests whether a supplement called ubiquinol (a form of coenzyme Q10) can reduce tiredness and help maintain muscle strength in people who are starting weight-loss injections like Wegovy or Mounjaro. If you qualify, you might receive the supplement or a placebo to see how it affects your energy and strength.
GlasgowAges 30–65 - NCT07881224RecruitingPhase 1
Fosmanogepix interaction and heart safety in healthy people
This early study checks how fosmanogepix, a medicine being tested, interacts with other drugs and whether it affects the heart's rhythm. It is for healthy adults to see how the body handles the drug and confirm it is safe before larger studies.
Groningen, NetherlandsAges 18–55 - NCT07879989Recruiting
Tracking breathing changes in adults with Duchenne muscular dystrophy
This study follows adults with Duchenne muscular dystrophy to track how their breathing changes over time. It aims to understand the natural progress of respiratory function, which may help improve future care and treatment planning.
BolognaAges 18 years+ - NCT07048262RecruitingPhase 2
Inhaled study treatment for adults with non-CF bronchiectasis
This study tests a new inhaled medicine (called CSL787) for people with bronchiectasis that is not caused by cystic fibrosis. It aims to see if the medicine can reduce chest infections and improve symptoms. You will receive the treatment as a mist you breathe in, and the study lasts for about a year.
QueenslandAges 18–85 - NCT07880717Recruiting
High body mass and gum disease in Thai adults
This study looks at how often high body mass index (BMI) and gum disease (periodontitis) occur together in Thai adults under 60. It may help researchers understand the link between weight and oral health, which could lead to better prevention and treatment.
Bangkok, RatchathewiAges 18–59 - NCT04419649RecruitingPhase 2
Elritercept for anemia in myelodysplastic syndromes
This study tests an investigational drug, elritercept, to see if it can improve anemia in people with certain types of myelodysplastic syndromes (MDS). It may reduce the need for red blood cell transfusions.
Hot Springs, ArkansasAges 18 years+ - NCT06244771RecruitingPhase 1/Phase 2
Study of a new drug for KRAS-mutated solid tumors
This trial tests a new drug, FMC-376, for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The drug may be given alone or with another medicine (pembrolizumab) to help the immune system fight the cancer.
La Jolla, CaliforniaAges 18 years+ - NCT07344779Recruiting
Darolutamide with hormone therapy for advanced prostate cancer
This study looks at how well the drug darolutamide works when combined with hormone therapy, with or without chemotherapy, for men whose prostate cancer has spread. It aims to see how effective this treatment is in everyday medical practice, not just in a research lab.
Many LocationsAges 18 years+ - NCT05685433Recruiting
Coil-shaped device for overactive bladder and urgent leaks
This study tests a small coin-shaped device (called eCoin) that is implanted near your ankle to deliver mild electrical pulses to a nerve that helps control bladder function. It's for people whose overactive bladder and urgent leaks haven't improved enough with other treatments, and it aims to reduce leakage and urgency.
Homewood, AlabamaAges 18 years+ - NCT06885034RecruitingPhase 1/Phase 2
Testing a new drug for advanced bowel or pancreatic cancer
This trial is testing an experimental drug (GSK5764227) either alone or with other treatments for people with advanced colon, rectal, or pancreatic cancer that cannot be removed with surgery. The goal is to see if the drug is safe and effective for these cancers.
Los Alamitos, CaliforniaAges 18 years+ - NCT07217717RecruitingPhase 3
New PET scan for pancreatic cancer staging
This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.
Cerritos, CaliforniaAges 18 years+ - NCT06982950Recruiting
How cannabis affects sleep in healthy adults
This study looks at how cannabis affects sleep. If you are a healthy adult who uses cannabis, you might be able to participate, but there are several strict health and lifestyle requirements.
Portland, OregonAges 21–29 - NCT05427370Recruiting
Compare bypass or stent treatment in weak heart patients
This study compares two ways to restore blood flow to the heart—bypass surgery (CABG) or stent procedure (PCI)—in people with a weak pumping heart. It looks at which approach works best when the heart muscle is not pumping well and there are multiple blocked heart arteries.
Los Angeles, CaliforniaAges 18 years+ - NCT07813039RecruitingPhase 1
Testing a new tablet form of an experimental medicine
This study tests how well a new tablet version of an experimental medicine (VX-581) is absorbed by the body. It may help researchers find the best way to give this medicine in the future.
Tempe, ArizonaAges 18–55 - NCT04339777RecruitingPhase 2
Bone marrow transplant for inherited immune system disorders
This trial studies how well a donor bone marrow (stem cell) transplant works for people with inherited immune system problems (called immune deficiencies). It’s for patients who haven’t improved with usual treatment or don’t have another good option.
Bethesda, MarylandAges 4–69 - NCT07668336RecruitingPhase 3
Study of two diabetes medicines for teens and children
This study tests an experimental daily pill (orforglipron) against an approved weekly injection (dulaglutide) in young people with type 2 diabetes. It aims to see which works better at controlling blood sugar and may offer a more convenient option.
Sacramento, CaliforniaAges 10–17 - NCT07221877RecruitingPhase 4
Study of KarXT for urological safety in schizophrenia
This study tests a new medicine (KarXT) for schizophrenia, focusing on how it affects urological (bladder and urinary) safety. You'll stop your current antipsychotic and take the study drug to see if it works well and is safe for your urinary system.
Little Rock, ArkansasAges 18–65
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.